TrialJournal of diabetes investigation2021

Phase III, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of teneligliptin monotherapy in Chinese patients with type 2 diabetes mellitus inadequately controlled with diet and exercise.

Linong Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.